Internal Medicine

IBD

By Isra IBS

Introduction

Inflammatory bowel disease (IBD) is an idiopathic disease caused by a dysregulated immune response to host intestinal microflora. The two major types of inflammatory bowel disease are:

Although UC and CD have distinct pathologic findings, approximately 10%-15% of patients cannot be classified definitively into either type; this is labeled as indeterminate colitis.

Both UC and CD usually have waxing and waning intensity and severity.

Comparison of Crohn’s Disease (CD) and Ulcerative Colitis (UC)
FeatureCrohn’s Disease (CD)Ulcerative Colitis (UC)
LocationAny part of the GI tract, mouth to anus, skip lesionsColon and rectum only, continuous lesions
DepthTransmural (all layers of bowel wall) may result in ulcers, transmural ulcers, resulting in fistula formationMucosa and submucosa only - rarely presents as feature of fistula formation
InflammationPatchy, granulomatousDiffuse, continuous
SymptomsAbdominal pain, diarrhea, weight loss, fatigue, feverBloody diarrhea, urgency, tenesmus, abdominal pain
ComplicationsStrictures, fistulas, abscesses, perianal diseaseToxic megacolon, perforation, colorectal cancer risk

Etiopathogenesis & Pathogenesis of IBD

IBD results from unregulated immune responses to gut commensals in genetically susceptible individuals. Cytokines, released by macrophages in response to various antigenic stimuli, cause differentiation of lymphocytes into different types of T cells.

  • Helper T cells, type 1 (Th-1): Principally associated with Crohn disease.
  • Th-2 cells: Principally associated with ulcerative colitis.

The immune response disrupts the intestinal mucosa and leads to a chronic inflammatory process.

\

Extraintestinal Manifestations of IBDZ

  • Arthritis: Peripheral arthritis, sacroiliitis (bamboo sign) - more in UC, spondylitis.
  • Skin: Erythema nodosum + pyoderma gangrenosum around stoma, extensor surfaces, injury sites - more in Crohn’s.
  • Mouth: Aphthous ulcers, stomatitis - more in Crohn’s.
  • Eyes: Anterior uveitis, scleritis, episcleritis - more in Crohn’s.
  • Anemia: Anemia of chronic disease in both.; microcytic
  • Clubbing
  • Primary sclerosing cholangitis: Associated with UC.

General Investigations for IBD

  • CBC: Anemia + leukocytosis - FLARE
  • High ESR and CRP: Especially with disease flare. -
  • Fecal calprotectin: To rule out IBS - C. deficille w/ antibiotic hx usagecc
  • Stool for ova and parasites, stool culture: To rule out infectious agents.

Top DIFF IBS, celiac, gastrointestinal infection

Specific Investigations: CD vs. UC

InvestigationCrohn’s Disease (CD)Ulcerative Colitis (UC)
AntibodiesASCA positiveP-ANCA positive
Barium SBFT/enemaString signLead pipe sign found also in Churg-Strauss syndrome
Colonoscopy/BiopsySkip lesions, cobblestoning, transmural ulcersFriable mucosa, pancolitis, submucosal ulcers, continuous lesions
MRICreepy appearance of fatLoss of architecture, lead pipe appearance
X-RayAir-fluid level, dilated loops (rule out SBO)Dilated colon ≥ 6 cm, pneumoperitoneum (toxic megacolon)

Treatment

Disease SeverityCrohn’s Disease (CD)Ulcerative Colitis (UC)
Mild to ModerateIleal: Oral budesonide → 6-MP or AZA
Colonic: 5-ASA → 5-ASA
5-ASA or budesonide → 5-ASA or (if no response to 5-ASA) 6-MP or AZA
Moderate to SeverePrednisone → AZA or 6-MP or InfliximabPrednisone → AZA or 6-MP or Infliximab
Severe/RefractoryMethylprednisolone or Infliximab → Vedolizumab or UstekinumabMethylprednisolone or Infliximab → Vedolizumab

Surgery: CD vs. UC

FeatureCrohn’s Disease (CD)Ulcerative Colitis (UC)
Curative?NoYes
IndicationComplications (strictures, fistulas, perianal disease); short bowel syndromeToxic megacolon, fulminant colitis, precancerous lesions
TypeConservative resectionTotal colectomy with ileal pouch-anal anastomosis (IPAA)

Surveillance

  • 8-10 years after diagnosis in all patients to stage histologic activity and guide future surveillance.
  • At diagnosis in primary sclerosing cholangitis = MOST LIKELY COLERECTAL CANCER.
  • Targeted to biopsy the suspicious mucosal abnormalities to rule out dysplasia.
  • Next colonoscopy is planned according to the degree of dysplasia: either annually, after 3 years, or after 5 years.



SURGERY

Idiopathic disease caused by a dysregulated immune response to host intestinal microflora.

Major types:

  • Ulcerative colitis (UC), which is limited to the colonic mucosa

  • Crohn disease (CD), which can affect any segment of the gastrointestinal tract from the mouth to the anus

  • Manifestations depend on the area of the intestinal tract involved

  • Not specific

World Gastroenterology Organization WGO

  • Diarrhea: Possible presence of mucus/blood in stool; occurs at night; incontinence
  • Constipation: May be the primary symptom in UC limited to the rectum
  • Bowel movement abnormalities: Possible presence of pain or rectal bleeding, severe urgency, tenesmus
  • Abdominal cramping : Commonly present in the RIF in CD; occur in the periumbilical or in the left lower quadrant in UC
  • Nausea and vomiting: More in CD than in UC

Diagnosis:

  • Labs: CBC, Serology (Perinuclear antineutrophil cytoplasmic antibodies (ANCA), anti-Saccharomyces cerevisiae antibodies (ASCA), Nutritional
  • Radiology:

    • Barium double-contrast enema radiographic studies
    • Abdominal ultrasonography
    • CT/MRI
  • Investigation procedures:

    • OGD/Colonoscopy, with biopsies
    • Capsule enteroscopy

Management:

Medical approach for symptomatic care, & mucosal healing

Surgical:

  • Resection is not curative in CD

if complications:

  • Perforation
  • Stricture
  • Fistula
  • Malignancy
  • Abscess/ collection

Table Comparision

FeatureUlcerative ColitisCrohn Disease
ExtentOnly colon involvedPanintestinal
Inflammation PatternContinuous, extending proximally from rectumSkip-lesions with intervening normal mucosa
Depth of InflammationMucosa and submucosaTransmural
Perianal LesionsAbsentPresent
GranulomasAbsentNoncaseating granulomas present
BleedingCommonUncommon
FistulaeRareCommon